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Abstract The brain integrates complex types of information,
and executes a wide range of physiological and behavioral
processes. Trillions of tiny organelles, the synapses, are central
to neuronal communication and information processing in the
brain. Synaptic transmission involves an intricate network of
synaptic proteins that forms the molecular machinery underly-
ing transmitter release, activation, and modulation of transmit-
ter receptors and signal transduction cascades. These processes
are dynamically regulated and underlie neuroplasticity, crucial
to learning and memory formation. In recent years, interaction
proteomics has increasingly been used to elucidate the
constituents of synaptic protein complexes. Unlike classic
hypothesis-based assays, interaction proteomics detects both
known and novel interactors without bias. In this trend article,
we focus on the technical aspects of recent proteomics to
identify synapse protein complexes, and the complementary
methods used to verify the protein–protein interaction.
Moreover, we discuss the experimental feasibility of
performing global analysis of the synapse protein interactome.
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Synapse background
The brain is the most complex and dynamically organized
organ, with high computation capability. It enables the
execution of a wide range of physiological processes and
behavior based on integrative neurotransmission among
neural systems and across brain regions. The fundamental
structural units for neuronal communication are the trillions
of chemical synapses. Each synapse consists of a neuro-
transmitter synthesizing and releasing apparatus, the presy-
napse, and a transmitter receiving element, the postsynapse.
An electric signal arriving at the presynaptic terminal is
converted into a chemical message in the form of released
transmitters, which diffuse through the synaptic cleft and
bind to the receptors in the postsynaptic element. This causes
differential ion fluxes into and out of the postsynapse that
may result in the propagation of electric signals in the
dendrite.
The molecular machinery underlying synaptic function
consists of an intricate network of synaptic proteins. It is
generally believed that neuronal activity-dependent change
of synaptic efficacy is at the basis of learning and memory
and is encoded by sequential molecular events at the
synapse. Abnormalities in synaptic activity or plasticity,
presumably underpinned by aberrant protein expression and/
or protein–protein interaction, are known to occur in many,
and maybe most, psychiatric disorders. Whereas the most
important aspects of synapse function, for example the
transmitter receptors, have been studied extensively, the
molecular basis of neuroplasticity remains largely unclear.
Revealing the mechanisms of synaptic plasticity and
synaptic disorders essentially needs to uncover the temporal
interactive actions of the multi-protein complexes that shape
synapse function. Classic studies focusing on single events
fall short of revealing the global changes of the system.
Proteomics has been used to examine the protein
constituents of the synapse sub-fractions including synaptic
vesicle [1, 2], pre-synapse element [3], and post-synaptic
density [4, 5]. Catalogs of sub-synapse proteomes now
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facilitate construction of a draft of a synapse protein
interactome [6, 7], however, understanding the organization
of macromolecular protein complexes and sub-synapse
structures that drive synapse function requires the identifi-
cation and quantification of protein constituents of synapse
protein complexes.
In the past year we have witnessed a major increase in
the application of interaction proteomics on the analysis of
brain synapses. Protein complexes have usually been
isolated by co-immunoprecipitation approach using anti-
bodies against the bait protein, and then subjected to MS-
based proteomics analysis. Tandem affinity purification
(TAP), a technique developed a decade ago for the large-
scale study of protein–protein interaction in yeast, has since
been shown to be applicable to the study of rodent synapse
protein complex [8]. From many of these studies meaning-
ful biological conclusions could be drawn. Subsequent
physiological studies revealed the roles protein interactions
play in driving synapse functions/neuroplasticity. Whereas
most of the studies focused on selected (single) bait
proteins, an attempt has also been made to assess the
experimental feasibility of carrying out a comprehensive
analysis of the synapse protein interactome [9].
Proteomics methodologies for analysis of synapse
protein complexes
A typical procedure for identifying a protein complex
requires affinity-isolation of the complex from a (pre-
fractionated) sample extracted in a detergent-containing
buffer. The purified protein complex is then subjected to
proteomics analysis (Fig. 1). The first proteomics study of a
synapse protein complex was reported a decade ago [10].
Throughout the years, interaction proteomics [11] has
emerged as a mature method. Continual advances in mass
accuracy and sensitivity in mass spectrometry greatly
facilitates protein identification. The establishment of large
number of proteomics centers has generated easy access to
this technology for many neuroscience groups. This has
contributed to a sharp increase in proteomics analysis of
synapse protein complexes in the past year, as summarized
in Table 1.
It is self-evident that synaptic protein complexes are
often isolated from input enriched in the synapse. In most
studies the input was a synaptosome-enriched fraction, or
the synaptic plasma membrane. Technical issues may also
dictate the type of input sample. For example, Han et al.
reported that use of the synaptosome fraction provided a
limited amount of materials for affinity purification of
protocadherin [12], whereas the crude membrane fraction
has high background. To circumvent the problem, the
authors used crude membrane protein extract as starting
material, and then reduced sample complexity, and thus
background, by incorporating sucrose density gradient
ultracentrifugation before affinity purification [12]. Whole
brain or brain regions have also been used without pre-
fractionation for isolation of protein complexes. The purpose
of these types of studies was to identify all the interacting
proteins of the bait proteins. In such cases, the synapse protein
interactors are a subset of the identified protein interactome.
The most widely used detergent for solubilization of
protein complexes is Triton X-100, usually in the range
0.5–1%, and up to 4% depending on protein concentration.
This non-ionic detergent effectively dissolves membranes,
and is mild enough to maintain (most) protein–protein
interactions. ComplexioLytes have been used to solubilize
receptors and ion channels. Unfortunately the chemical
compositions of these detergents are unknown. In some
cases, the ionic detergent sodium deoxycholate (DOC) has
been used. This is exemplified by the isolation of PSD-95
complex. PSD-95 is partially soluble in Triton X-100; this
soluble fraction has been shown to contain multiple protein
complexes [9]. Most PSD-95 is embedded in the post-
synaptic density, which is not soluble in Triton X-100 [4].
One percent DOC, which has been shown to solubilize core
post-synaptic density protein, for example the NMDA
receptor [10], was chosen [8] to solubilize PSD-95 directly
from mouse forebrain. The complex was then isolated by
target affinity tagging (TAP). It should be noted that DOC
has been shown to have an adverse effect on protein–
protein interactions, resulting in poor recovery of the intact
protein complex [21]. The detected proteins may be a small
fraction of the proteins that still retain interaction. Alterna-
tively, they may represent secondary interaction to the bait
protein that has been stripped from its interactors [22].
The isolated protein complex is commonly fractionated
with SDS-PAGE, which separates proteins according to
their masses. In some cases the protein pattern of the
stained gel from the sample was compared with that of a
negative control; protein bands specifically present in the
sample lane were digested with trypsin, and analyzed either
directly by mass spectrometry or by LC–MS–MS (Table 1).
The disadvantage is that proteins existing at levels lower
than the detection limit of the staining method would not be
selected for further analysis. As current MS sensitivity is at
the low femtomole to the upper attomole level, it surpasses
the detection limit of silver stained gel, leading to the
preferred analysis to cut whole gel lanes into pieces,
irrespective of the staining pattern, followed by trypsin
digestion and analysis by LC–MS–MS. Comparison of the
sample with a negative control then reveals the true protein
interactors. The ideal negative control would be an identical
analysis, using sample from a (knockout) mouse lacking the
bait protein [12], or the use of multiple antibodies directed
at the same protein.
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Different types of mass spectrometer have been used for
protein identification [23]. Because of the high mass
accuracy in the MS1 and fast scan rate and high sensitivity
in MS–MS, ion trap-FT MS appears to be the preference.
Off-line LC MALDI TOF–TOF mass spectrometry has
generally been used for iTRAQ reagent-based protein
quantitation [7, 18] because it yields intense iTRAQ
signature ions and gives a good coverage of peptide b-ion
and y-ion series. Other studies have shown that online LC–
electrospray MS–MS can also be optimized for iTRAQ
reagent based quantitation [24, 25].
Affinity tagging for the analysis of selected protein
complex
The classical approach used to isolate a protein complex is
to use a specific antibody against the bait protein for co-
immunoprecipitation. The success of such an experiment
critically depends on the quality of the antibody. To obtain
the best result it is not uncommon to use several antibodies
against different epitopes of a protein [13] to increase the
validity of the study.
Recently, TAP tagging methodology with a gene-
targeting approach in mice has been used, with PSD-95 as
a model [8]. First, a knockin mouse was generated with a
TAG tag of a poly-histidine affinity tag (HAT) and a triple
FLAG tag, in tandem attached at the C-terminal of a PSD-
95 construct. A TEV-protease cleavage site separated the
HAT and FLAG tags. Second, it was confirmed that the
expression level and synapse localization of the TAP-
tagged PSD-95 were similar to those of endogenous PSD-
95 and that the knocked-in gene did not alter the synapse
physiology. Third, the soluble PSD-95 was captured by a
FLAG antibody covalently coupled to beads. The beads
were incubated with TEV that cut the TEV-protease
cleavage site between the HAT and FLAG tags. The
released PSD-95 containing HAT tag was recovered by
(3) Peptide
IP1 IP2MW
(1) Acidic Buffer (2) SDS Sample Buffer
Enrichment of 
Synapse
Extraction of Protein
Complexes
Immunoisolation of 
Protein Complexes
Elution
Digestion of 
Proteins
LC-MS/MS Analysis
Separation on
SDS-PAGE
Tissue Dissection
Fig. 1 Workflow of
immunoprecipitation-based pro-
teomics of synapse protein
complexes. Brain tissue is ho-
mogenized, and subjected to one
or a series of differential centri-
fugation steps optimized to en-
rich synapses. After extraction
of the sample in a detergent-
containing buffer, antibodies
against a specific synaptic pro-
tein and the protein A/G beads
are added and incubated for
from 1 h to overnight. The
antibody-captured protein com-
plexes can be eluted using dif-
ferent strategies. (1) Acidic
buffer elution. This step is often
followed by an in-solution di-
gest. (2) SDS sample buffer
elution. This step dislodges all
the non-covalently bound pro-
teins from the beads. (3) Elution
with a high concentration of
peptide/protein antigen. This
generally gives lowest back-
ground proteins. In (2) and (3),
the eluted proteins are usually
run on an SDS-PAGE and then
digested in-gel. In all cases the
peptide mixtures are further an-
alyzed by LC–MS–MS
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use of an Ni2+-NTA column that binds HAT, and
subsequently eluted with imidazole. The PSD-95 complex
was separated by SDS-PAGE, trypsin digested, and
analyzed by LC–MS–MS. Compared with single-step
purification, tandem purification results in fewer contami-
nants. It also detected more low-abundance proteins that
could have been masked by the high-abundance proteins in
a single purification. Hundreds of proteins were identified.
They were connected into a protein network, using protein–
protein interaction data from manually-curated interaction
data and the UniHi database. Annotation of the clusters
with human disease associations revealed that multiple
disorders map to the network, with a significant correlation
of schizophrenia within the glutamate receptor clusters.
However, the in-vivo affinity tag approach involves a
tedious procedure to generate the knockin mouse, and to
control for the normal functioning of the mutated protein.
This approach is therefore applicable to only a limited set of
synapse proteins for in-depth analysis.
A similar TAP approach has been used to identify the
interacting proteins of metabotropic glutamate receptor 1
transfected in Madin–Darby canine kidney cells [26]. Several
of the identified interactors were shown to associate with the
native receptor in the brain by co-immunoprecipitation and
western blotting.
Other tags may be used for affinity isolation of a protein
complex. For example, affinity purification with anti-GFP
antibody from the brain extract of a PCDH-γ-GPF knockin
mice has been used for isolation of the PCDH-γ protein
complex [12].
Validating protein–protein interactions
A general problem in affinity proteomics is distinguishing
specific interactors from contaminants. For example,
mitochondrial proteins, proteins involved in metabolism,
and cytoskeletal proteins are often detected across IP
studies. These proteins are highly abundant. They may not
be completely removed during washing steps, and are,
therefore, identified subsequently. To address this problem,
we have used iTRAQ reagent for comparative analysis of
an AMPA receptor complex isolated from wild type and
knockout mice [18]. Proteins enriched in the wild type mice
as indicated by high iTRAQ ratio in the wild type mice
sample represent true interactors of the AMPA receptor.
Other studies compared the proteins identified from the
affinity purification with the specific antibody and the
negative control, respectively. Proteins with high relative
peptide query score were regarded as specific interactors
[13, 14].
Reversed immunoprecipitation is generally used as an
independent method to verify protein–protein interaction
data (Table 1), i.e. immunoprecipitation of the interactor co-
immunoprecipitates the original bait protein. In studies that
identified large numbers of proteins without subsequent
verification of the interactions, in particular for those in
which a negative control was not included, some of the
reported proteins may be contaminants [8, 9, 15].
In principle, yeast two hybrid assay can also be used to
probe the binary protein–protein interaction; but today it is
sparsely used to confirm the interaction detected by
interaction proteomics.
Single proteins might be involved in multiple events in
the synapse. Hence, they might be contained in different
protein complexes. Therefore, affinity isolation of a bait
protein might capture multiple protein complexes, which
are characterized simultaneously by proteomics without
distinguishing proteins residing in distinct protein com-
plexes. How can an identified protein be assigned to
multiple protein complexes? Blue native polyacrylamide
gel electrophoresis (BN-PAGE) separates stable protein
complexes according to their sizes with good resolution up
to around 1,200 kDa. BN-PAGE is a method of choice to
confirm and/or differentiate protein constituents from
protein complexes, as exemplified by the analyses of
AMPA receptor complexes. VandenBerghe et al. [27],
solubilized a cerebellar extract and pre-fractionated on a
10–50% glycerol gradient; the fractions were then analyzed
by BN-PAGE. The AMPA receptors containing subunits 2/
3 migrated as two distinct high-molecular-weight com-
plexes. The well established AMPA receptor interactor,
stargazing, co-migrated with one of them, suggesting the
presence of an additional AMPA receptor complex. A
recent study [13] revealed that this distinct AMPA receptor
complex contains cornichon. BN-PAGE in conjunction
with antibody shift and western blotting analysis confirmed
the mutual exclusive existence of stargazing and cornichon
in these two AMPA receptor complexes.
The demonstration that potential interactors exist in close
proximity at the sub-cellular level is often used as
supporting evidence of their in-situ interaction. Immunocy-
tochemistry is routinely applied for co-localization studies,
but the spatial resolution is too low to verify protein–
protein interaction. Fluorescent resonance energy transfer
enables in-cell visualization of protein pairs [28] at a
distance of typically less than 10 nm. This method requires
the transfection, usually in a cell culture, of the potential
interacting protein pair, one with a donor chromophore and
the other with an acceptor chromophore. The disadvantages
are that this method detects the transfected proteins rather
than the endogenous proteins, and that the presence of the
chromophores may affect protein interaction. Recently, an
antibody-based proximity ligation assay (PLA) technology
was developed to study protein–protein interaction in situ
[29, 30]. The sample is incubated with two target-specific
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primary antibodies from two different host species. After
washing, two PLA probes, each with a species-specific
secondary antibody with a short DNA strand, are added. If
the two proteins are in close proximity, and in the presence of
the added circle-forming DNA oligonucleotides, the DNA
strands from the two antibodies hybridize to form a circular
DNA. This DNA can then be amplified and detected with
fluorescent probes. As antibodies against synaptic proteins
are widely available, this technique should be applicable for
specific analysis of interactions in the synaptic protein
interactome. A proof-of-principle experiment for high-
content high-throughput analysis of protein–protein interac-
tion using PLA on an automatic fluorescence microscope,
cellomics, was recently demonstrated [31].
Reproducibility and overlap between studies
Interaction proteomics studies (Table 1) often generate
useful protein–protein interaction information giving better
insight into the regulation of the bait proteins. A recurring
question is: how complete is the proteomics analysis?
AMPA receptor research has provided a good test case. The
AMPA receptors are the most studied synaptic proteins,
because of their central role in controlling synapse function
and plasticity. In recent months several novel AMPA
receptor interactors have been reported, including corni-
chon [13], CKAMP44 [18] and GEF-H1 [17]. These
proteins modulate the properties of AMPA receptor channel
in distinct manners, and play important roles in synapse
plasticity. Why have these new interactors not been
detected previously? Cornichon is a small protein,
<20 kDa, and may run together with the front on a 10%
SDS-PAGE; small proteins are often ignored in routine
analysis. In another study [18] not involving the use of
SDS-PAGE, the total trypsin digest of the sample was
fractionated by LC and analyzed by MALDI TOF–TOF
MS. The MS mass range of 850–2700 Da covers only the
mass of a single tryptic peptide of cornichon. This peptide
was masked by other co-eluting peptides, and not charac-
terized. CKAMP44 was identified with a number of
peptides [18]. However, this novel protein is not annotated
in SwissProt, and would not have been identified if this
database had been used. GEF-H1 is another novel AMPA
receptor interactor. The affinity isolation procedure [17]
deviated from the other procedures in that it consisted of a
wheat germ agglutinin chromatography step to enrich
membrane proteins before they were subjected to large-
scale immunoprecipitation. Furthermore, it is not unlikely
that the co-localization of the AMPA receptor and GEF-H1
to the dendritic spine, and thus their interaction, is regulated
by neuronal activity [32]. Finally, the differences may be
because of trivial technical issues such as under-sampling in
the mass spectrometer, and the interference of tags or
epitopes required for enrichment with binding of members
in the protein complex.
Towards global analysis of the synapse protein
interactome
Synapses are rather simple, well-defined structures with
probably two thousand different types of proteins present
(excluding the synaptic mitochrondrial genome and specific
posttranslational modifications). Considering the similar
complexity of, for instance, yeast, a systems biology
analysis of the synapse seems feasible. The prerequisite is
that a large number of high-quality antibodies against
synaptic proteins are readily available. Commercial anti-
bodies are generally too expensive to be used for global co-
immunoprecipitation experiments. Recently, a cooperative
venture was established between the University of Cal-
ifornia at Davis, the National Institutes of Health, and
Antibodies Inc. It now provides >200 low-cost, good
quality monoclonal antibodies against diverse classes of
synapse proteins. In a recent study, antibodies from this
venture have been used to examine the protein complexes
of PSD-95, CASK, KCNQ2, Kv4.2, CaVβ4, and GIT1 [9].
A simple synapse network was constructed, demonstrating
the complexity of the protein interaction.
Large-scale proteomics analyses of synapse protein
complexes are now in progress (the EU 7th-framework
health, SynSys, and Eurospin initiatives). The workflow for
the analysis is shown in Fig. 2. The objectives of this large-
scale study spanning four years are to identify the protein
network underlying synapse function and to translate this
into a realistic dynamical model of the synapse. Certainly, a
challenge in the coming years is the further development of
data-analysis tools that include proper means of tagging
identified protein–protein interactions with a probability or
fidelity score, and the visualization tools that give biolog-
ical insight of the (dynamics of) the synapse protein
interactome.
Outlook
Proteomics analyses of synapse protein complexes continue
to identify the associated proteins; functional studies will
answer how these proteins form a functional unit. The TAP
technique will be applied to studies of several key synapse
proteins. A major new development is the global analysis of
synapse protein complexes, using hundreds of antibodies
raised across different classes of synapse proteins. This will
be supplemented by large-scale studies with BN-PAGE and
proximity ligation immunocytochemistry to confirm pro-
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tein–protein interactions. To develop interaction proteomics
analysis to a new level of biological relevance one major
focus will be to provide a dynamic model of the
interactome based on challenges of the synapse network
using well-defined stimuli (e.g. synaptic stimulation) and
using a collection of mouse mutants with (null) mutations
for synaptic genes. Experiments using biologically relevant
stimuli will yield information on the dynamic behavior of
the protein network and it will allow us to study the spatio-
temporal pattern of the synaptic protein interactome rather
than solely describing static protein interaction within a
cell. These experiments will be crucial to understanding the
meaning of protein complexes in the context of signal
transduction and synaptic plasticity. In addition, interac-
tome analysis of synaptic mutants will reveal changes in
the network that can be used to provide models of
synaptic (dys)function of human diseases. We expect that
within five years a comprehensive synapse protein
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Fig. 2 Work flow for global analysis of synaptic protein complexes.
Global analysis of the synaptic protein interactome requires hundreds
of high-quality antibodies. We routinely use antibodies that are
applicable for western blot analysis, and use this analysis for quality
control of the IP experiment. IP is performed in detergent-solubilized
samples, thus the efficiency of extraction of the protein of interest by
the selected detergent must be checked beforehand. This step can be
coupled with analysis of sub-cellular localization in term of
enrichment of the protein in different synaptic sub-domains (for
example the synaptosome, microsome, synaptic membrane, postsyn-
aptic density, and lipid raft). Next, a test IP with Triton X-100-
extracted complexes is performed followed by immunoblotting
analysis to determine the recovery of the protein. On the basis of
this result the immunoisolation procedure is optimized by changing
the amounts of input material, antibody, and/or the protein A/G beads.
Proteins enriched in the PSD and lipid rafts are partly, or not, soluble
in buffers containing Triton X-100. These proteins are then extracted
with stronger detergents (for example, DOC). After optimization, an
IP followed by LC–MS–MS analysis is performed, with several
biological replicates to estimate the sample variation
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interactome will be constructed, and the dynamics of the
protein complexes will have started to be mapped. This
will provide insight into synapse function, and under-
standing of how synaptic complex dysfunction leads to
various brain disorders.
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